Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Milton

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
American Journal of Hematology|July 18, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experienceOren Pasvolsky, Denái R Milton, Adeel Masood, et al.
Neurology|December 29, 2005
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disordersA J Allen, R M Kurlan, D L Gilbert, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer Discovery|October 10, 2015
Dual Roles of RNF2 in Melanoma ProgressionKunal Rai, Kadir C Akdemir, Lawrence N Kwong, et al.
Blood Advances|October 7, 2020
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MMNeeraj Saini, Qaiser Bashir, Denái R Milton, et al.
Blood Cancer Journal|June 5, 2026
D-VRD induction and autologous transplant in patients ≥70 yearsOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Neuro-Oncology Advances|February 10, 2026
Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgeryTroy J Kleber, Denái R Milton, Subhiksha Srinivasan, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
British Journal of Haematology|November 29, 2024
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplantCurtis Marcoux, Sarah Pasyar, Denái R Milton, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
American Journal of Hematology|July 18, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experienceOren Pasvolsky, Denái R Milton, Adeel Masood, et al.
Neurology|December 29, 2005
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disordersA J Allen, R M Kurlan, D L Gilbert, et al.
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer Discovery|October 10, 2015
Dual Roles of RNF2 in Melanoma ProgressionKunal Rai, Kadir C Akdemir, Lawrence N Kwong, et al.
Blood Advances|October 7, 2020
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MMNeeraj Saini, Qaiser Bashir, Denái R Milton, et al.
Blood Cancer Journal|June 5, 2026
D-VRD induction and autologous transplant in patients ≥70 yearsOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Neuro-Oncology Advances|February 10, 2026
Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgeryTroy J Kleber, Denái R Milton, Subhiksha Srinivasan, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
British Journal of Haematology|November 29, 2024
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplantCurtis Marcoux, Sarah Pasyar, Denái R Milton, et al.
Pageof 19